ELLINGTON MANAGEMENT GROUP LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 103 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$183,000
-37.3%
21,664
-18.9%
0.05%
-26.8%
Q2 2015$292,000
-32.3%
26,700
+4.7%
0.07%
-50.3%
Q4 2014$431,000
-31.3%
25,500
-34.1%
0.14%
+20.2%
Q2 2013$627,00038,7000.12%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
BVF INC/IL 15,232,268$29,094,0002.84%
EcoR1 Capital, LLC 412,000$787,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 1,130,432$2,159,0000.05%
ESSEX INVESTMENT MANAGEMENT CO LLC 164,605$314,0000.04%
Clear Harbor Asset Management, LLC 95,630$183,0000.03%
ALGERT GLOBAL LLC 72,556$139,0000.03%
180 WEALTH ADVISORS, LLC 30,000$57,0000.03%
GSA CAPITAL PARTNERS LLP 289,854$554,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 85,412$163,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$877,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders